Extract notice to the Minister
Erivedge (carcinome basocellulaire)
Common name / Subject : Vismodegib
Name of the manufacturer : Roche
Form : Caps.
Dosage : 150 mg
Name of the manufacturer : Roche
Form : Caps.
Dosage : 150 mg
Indication : Carcinome basocellulaire
INESSS' Recommendation
-
Minister's decisions
Inscrire aux listes des médicaments – Médicament d’exception (2018-05-24)
Evaluation published on May 24, 2018